PF-06741086 Long-term Treatment in Severe Hemophilia

Clinical trial NCT03363321 · COMPLETED

Trial details

NCT number: NCT03363321
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hemophilia A or B

Start date: 2018-05-30
Primary completion: 2020-08-05
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.